全体要約
整形外科再生医療市場は、2022年の売上高を基に、2023年から2029年にかけての予測を地域別、セクター別に分析しています。市場は、幹細胞治療、プラズマベース療法、組織工学などの製品タイプに分かれ、アメリカ、ヨーロッパ、中国などの主要地域での成長が見込まれています。主要企業には、Ortho Regenerative Technologies IncやAnika Therapeutics Incなどが含まれ、2022年には上位2社が市場の大部分を占めました。
このレポートは、整形外科再生医療の市場動向、ドライバー、影響要因を評価し、アプリケーション別に骨関節疾患、リウマチ性関節炎、靭帯損傷などの機会を強調しています。市場規模は2022年から2029年にかけて成長が予測されており、特にアメリカ、中国、ヨーロッパでの成長が期待されています。
関連する質問
Ortho Regenerative Technologies Inc, Personalized stem cells Inc., Anika Therapeutics Inc., Arthrex Inc., Baxter International Inc., Conmed Corporation, Aziyo Biologics, Curasan Inc., Swiss biomed Orthopedics AG, Octane Medical Inc., Stryker Corporation, Carmell Therapeutics Corporation, Zimmer Holdings, Smith & Nephew plc., NuVasive Inc.
製品セグメンテーションの重要なトレンド, 企業の形成と市場シェア, 地理的フットプリントの分析
概要
このインサイトレポートは、世界の整形外科再生医療の状況を包括的に分析し、製品セグメンテーション、企業の設立、収益、市場シェア、最新の開発、M&A活動に関連する重要なトレンドを強調しています。また、このレポートでは、整形外科再生医療ポートフォリオや能力、市場参入戦略、市場の地位、地理的な展開に焦点を当て、リーディンググローバル企業の戦略を分析し、加速する世界の整形外科再生医療市場におけるこれらの企業の独自の位置をよりよく理解することを目的としています。
このインサイトレポートは、整形外科再生医療の世界的な展望を形成する主要な市場動向、ドライバー及び影響要因を評価し、予測をタイプ別、アプリケーション別、地理的要因別、市場規模別に分解して、新たな機会のポケットを強調します。数百のボトムアップの質的および量的市場インプットに基づく透明な方法論を用いたこの調査予測は、整形外科再生医療における現在の状況と将来の軌道について、非常に微妙な視点を提供します。
グローバル整形外科再生医療市場の規模は、2022年のXX米ドルから2029年のXX米ドルに成長すると予想されており、2023年から2029年の間にCAGRでXX%の成長が見込まれています。
アメリカの整形外科再生医療市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると見込まれており、2023年から2029年までの間にXX%のCAGRで成長する見込みです。
中国の整形外科再生医療市場は、2022年のXX米ドルから2029年までにXX米ドルに増加する見込みであり、2023年から2029年の間にXX%のCAGRを記録する予想です。
ヨーロッパの整形外科再生医療市場は、2022年のXX米ドル円から2029年にはXX米ドル円に増加すると見込まれており、2023年から2029年までの間にXX%の CAGR を記録する見込みです。
グローバルな主要整形外科再生医療企業には、Ortho Regenerative Technologies Inc、Personalized stem cells Inc.、Anika Therapeutics Inc.、Arthrex Inc.、Baxter International Inc.、Conmed Corporation、Aziyo Biologics、Curasan Inc.、およびSwiss biomed Orthopedics AGなどが含まれます。2022年の収益に関して、グローバルにおいて2社が占めるシェアはほぼXX%でした。
このレポートは、製品タイプ、アプリケーション、主要プレーヤー、主要地域および国別の整形外科再生医療市場の包括的な概要、市場シェア、および成長機会を示しています。
市場セグメンテーション：
種類別のセグメンテーション
幹細胞療法（同種骨、自家骨、骨移植）
プラズマベース療法
組織工学（同種移植）
アプリケーション別のセグメンテーション
骨関節疾患
関節リウマチ
靭帯損傷
滑液包炎
骨粗しょう症
この報告書では、市場を地域別に分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の会社は、一次専門家から得られた情報や、企業のカバレッジ、製品ポートフォリオ、市場浸透率を分析した結果に基づいて選定されています。
オーソ再生医療技術株式会社
パーソナライズド幹細胞株式会社
アニカセラピューティクス社
アースレックス社
バクスターインターナショナル株式会社
コンメッド株式会社
アジヨ バイオロジクス
キュラサン株式会社
スイス・バイオメッド・オーソペディクスAG
オクタンメディカル株式会社
ストライカー社
カーメル・セラピューティクス株式会社
ジマー・ホールディングス
スミス・アンド・ネフュー plc.
ヌーバサイズ社
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの整形外科再生医療市場規模、（2018年～2029年）
2.1.2 整形外科再生医療市場規模、CAGR（地域別）（2018年 vs 2022年 vs 2029年）
2.2 整形外科再生医療セグメント、タイプ別
2.2.1 幹細胞治療（同種骨、自家骨、骨移植）
2.2.2 プラズマベース療法
2.2.3 組織工学（同種移植片）
2.3 整形外科再生医療市場規模：タイプ別
2.3.1 整形外科再生医療市場規模、CAGR（タイプ別）（2018年 vs 2022年 vs 2029年）
2.3.2 グローバルの整形外科再生医療市場規模、市場シェア（タイプ別）（2018年～2023年）
2.4 整形外科再生医療セグメント、用途別
2.4.1 骨関節疾患
2.4.2 関節リウマチ
2.4.3 靭帯損傷
2.4.4 滑液包炎
2.4.5 骨粗鬆症
2.5 整形外科再生医療市場規模：用途別
2.5.1 整形外科再生医療市場規模、CAGR（用途別）（2018年 vs 2022年 vs 2029年）
2.5.2 グローバルの整形外科再生医療市場規模、市場シェア（用途別）（2018年～2023年）
3 整形外科再生医療市場規模：プレイヤー別
3.1 整形外科再生医療市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおける整形外科再生医療市場の収益規模、プレイヤー別（2018年～2023年）
3.1.2 グローバルにおける整形外科再生医療市場の収益シェア、プレイヤー別（2018年～2023年）
3.2 グローバルの整形外科再生医療市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2021年～2023年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 整形外科再生医療、地域別
4.1 整形外科再生医療市場規模（地域別）（2018年～2023年）
4.2 アメリカズにおける整形外科再生医療市場規模成長（2018年〜2023年）
4.3 APACにおける整形外科再生医療市場規模成長（2018年〜2023年）
4.4 ヨーロッパにおける整形外科再生医療市場規模成長（2018年〜2023年）
4.5 中東・アフリカにおける整形外科再生医療市場規模成長（2018年〜2023年）
5 アメリカズ
5.1 アメリカズにおける整形外科再生医療市場規模、国別（2018年〜2023年）
5.2 アメリカズにおける整形外科再生医療市場規模、タイプ別（2018年〜2023年）
5.3 アメリカズにおける整形外科再生医療市場規模、用途別（2018年〜2023年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける整形外科再生医療市場規模、地域別（2018年〜2023年）
6.2 APACにおける整形外科再生医療市場規模、タイプ別（2018年〜2023年）
6.3 APACにおける整形外科再生医療市場規模、用途別（2018年〜2023年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパの整形外科再生医療 国別（2018年～2023年）
7.2 ヨーロッパにおける整形外科再生医療市場規模、タイプ別（2018年〜2023年）
7.3 ヨーロッパにおける整形外科再生医療市場規模、用途別（2018年〜2023年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカの整形外科再生医療 地域別（2018年～2023年）
8.2 中東・アフリカにおける整形外科再生医療市場規模、タイプ別（2018年〜2023年）
8.3 中東・アフリカにおける整形外科再生医療市場規模、用途別（2018年〜2023年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルの整形外科再生医療市場、市場予測
10.1 グローバルの整形外科再生医療、市場予測（地域別）（2024年～2029年）
10.1.1 グローバルの整形外科再生医療、市場予測（地域別）（2024年～2029年）
10.1.2 アメリカズの整形外科再生医療、市場予測
10.1.3 APACの整形外科再生医療、市場予測
10.1.4 ヨーロッパの整形外科再生医療、市場予測
10.1.5 中東・アフリカの整形外科再生医療、市場予測
10.2 アメリカズの整形外科再生医療、市場予測（国別）（2024年～2029年）
10.3 APACの整形外科再生医療、市場予測（地域別）（2024年～2029年）
10.4 ヨーロッパの整形外科再生医療、市場予測（国別）（2024年～2029年）
10.5 中東・アフリカの整形外科再生医療、市場予測（地域別）（2024年～2029年）
10.6 グローバルの整形外科再生医療、市場予測（タイプ別）（2024年～2029年）
10.7 グローバルの整形外科再生医療、市場予測（用途別）（2024年～2029年）
11 キープレイヤー分析
11.1 Ortho Regenerative Technologies Inc
11.1.1 Ortho Regenerative Technologies Inc：企業情報
11.1.2 Ortho Regenerative Technologies Inc：整形外科再生医療分野の提供製品
11.1.3 Ortho Regenerative Technologies Inc：整形外科再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.1.4 Ortho Regenerative Technologies Inc：主要事業概要
11.1.5 Ortho Regenerative Technologies Inc：直近の展開
11.2 Personalized stem cells Inc
11.3 Anika Therapeutics Inc
11.4 Arthrex Inc
11.5 Baxter International Inc
11.6 Conmed Corporation
11.6.1 Conmed Corporation：企業情報
11.6.2 Conmed Corporation：整形外科再生医療分野の提供製品
11.6.3 Conmed Corporation：整形外科再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.6.4 Conmed Corporation：主要事業概要
11.6.5 Conmed Corporation：直近の展開
11.7 Aziyo Biologics
11.7.1 Aziyo Biologics：企業情報
11.7.2 Aziyo Biologics：整形外科再生医療分野の提供製品
11.7.3 Aziyo Biologics：整形外科再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.7.4 Aziyo Biologics：主要事業概要
11.7.5 Aziyo Biologics：直近の展開
11.8 Curasan Inc
11.9 Swiss biomed Orthopedics AG
11.9.1 Swiss biomed Orthopedics AG：企業情報
11.9.2 Swiss biomed Orthopedics AG：整形外科再生医療分野の提供製品
11.9.3 Swiss biomed Orthopedics AG：整形外科再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.9.4 Swiss biomed Orthopedics AG：主要事業概要
11.9.5 Swiss biomed Orthopedics AG：直近の展開
11.10 Octane Medical Inc
11.11 Stryker Corporation
11.11.1 Stryker Corporation：企業情報
11.11.2 Stryker Corporation：整形外科再生医療分野の提供製品
11.11.3 Stryker Corporation：整形外科再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.11.4 Stryker Corporation：主要事業概要
11.11.5 Stryker Corporation：直近の展開
11.12 Carmell Therapeutics Corporation
11.12.1 Carmell Therapeutics Corporation：企業情報
11.12.2 Carmell Therapeutics Corporation：整形外科再生医療分野の提供製品
11.12.3 Carmell Therapeutics Corporation：整形外科再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.12.4 Carmell Therapeutics Corporation：主要事業概要
11.12.5 Carmell Therapeutics Corporation：直近の展開
11.13 Zimmer Holdings
11.13.1 Zimmer Holdings：企業情報
11.13.2 Zimmer Holdings：整形外科再生医療分野の提供製品
11.13.3 Zimmer Holdings：整形外科再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.13.4 Zimmer Holdings：主要事業概要
11.13.5 Zimmer Holdings：直近の展開
11.14 Smith & Nephew plc
11.15 NuVasive Inc
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
This Insight Report provides a comprehensive analysis of the global Orthopedic Regenerative Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orthopedic Regenerative Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Orthopedic Regenerative Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orthopedic Regenerative Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orthopedic Regenerative Medicine.
The global Orthopedic Regenerative Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Orthopedic Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Orthopedic Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Orthopedic Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Orthopedic Regenerative Medicine players cover Ortho Regenerative Technologies Inc, Personalized stem cells Inc., Anika Therapeutics Inc., Arthrex Inc., Baxter International Inc., Conmed Corporation, Aziyo Biologics, Curasan Inc. and Swiss biomed Orthopedics AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Orthopedic Regenerative Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Stem Cell Therapy (Allogeneic Bones, Autogeneic Bones, and Bone Grafting)
Plasma Based Therapy
Tissue Engineering (Allograft)
Segmentation by application
Osteoarticular Diseases
Rheumatoid Arthritis
Ligament Injuries
Bursitis
Osteoporosis
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ortho Regenerative Technologies Inc
Personalized stem cells Inc.
Anika Therapeutics Inc.
Arthrex Inc.
Baxter International Inc.
Conmed Corporation
Aziyo Biologics
Curasan Inc.
Swiss biomed Orthopedics AG
Octane Medical Inc.
Stryker Corporation
Carmell Therapeutics Corporation
Zimmer Holdings
Smith & Nephew plc.
NuVasive Inc.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Orthopedic Regenerative Medicine Market Size 2018-2029
2.1.2 Orthopedic Regenerative Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Orthopedic Regenerative Medicine Segment by Type
2.2.1 Stem Cell Therapy (Allogeneic Bones, Autogeneic Bones, and Bone Grafting)
2.2.2 Plasma Based Therapy
2.2.3 Tissue Engineering (Allograft)
2.3 Orthopedic Regenerative Medicine Market Size by Type
2.3.1 Orthopedic Regenerative Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Orthopedic Regenerative Medicine Market Size Market Share by Type (2018-2023)
2.4 Orthopedic Regenerative Medicine Segment by Application
2.4.1 Osteoarticular Diseases
2.4.2 Rheumatoid Arthritis
2.4.3 Ligament Injuries
2.4.4 Bursitis
2.4.5 Osteoporosis
2.5 Orthopedic Regenerative Medicine Market Size by Application
2.5.1 Orthopedic Regenerative Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Orthopedic Regenerative Medicine Market Size Market Share by Application (2018-2023)
3 Orthopedic Regenerative Medicine Market Size by Player
3.1 Orthopedic Regenerative Medicine Market Size Market Share by Players
3.1.1 Global Orthopedic Regenerative Medicine Revenue by Players (2018-2023)
3.1.2 Global Orthopedic Regenerative Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Orthopedic Regenerative Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Orthopedic Regenerative Medicine by Regions
4.1 Orthopedic Regenerative Medicine Market Size by Regions (2018-2023)
4.2 Americas Orthopedic Regenerative Medicine Market Size Growth (2018-2023)
4.3 APAC Orthopedic Regenerative Medicine Market Size Growth (2018-2023)
4.4 Europe Orthopedic Regenerative Medicine Market Size Growth (2018-2023)
4.5 Middle East & Africa Orthopedic Regenerative Medicine Market Size Growth (2018-2023)
5 Americas
5.1 Americas Orthopedic Regenerative Medicine Market Size by Country (2018-2023)
5.2 Americas Orthopedic Regenerative Medicine Market Size by Type (2018-2023)
5.3 Americas Orthopedic Regenerative Medicine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Orthopedic Regenerative Medicine Market Size by Region (2018-2023)
6.2 APAC Orthopedic Regenerative Medicine Market Size by Type (2018-2023)
6.3 APAC Orthopedic Regenerative Medicine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Orthopedic Regenerative Medicine by Country (2018-2023)
7.2 Europe Orthopedic Regenerative Medicine Market Size by Type (2018-2023)
7.3 Europe Orthopedic Regenerative Medicine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Orthopedic Regenerative Medicine by Region (2018-2023)
8.2 Middle East & Africa Orthopedic Regenerative Medicine Market Size by Type (2018-2023)
8.3 Middle East & Africa Orthopedic Regenerative Medicine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Orthopedic Regenerative Medicine Market Forecast
10.1 Global Orthopedic Regenerative Medicine Forecast by Regions (2024-2029)
10.1.1 Global Orthopedic Regenerative Medicine Forecast by Regions (2024-2029)
10.1.2 Americas Orthopedic Regenerative Medicine Forecast
10.1.3 APAC Orthopedic Regenerative Medicine Forecast
10.1.4 Europe Orthopedic Regenerative Medicine Forecast
10.1.5 Middle East & Africa Orthopedic Regenerative Medicine Forecast
10.2 Americas Orthopedic Regenerative Medicine Forecast by Country (2024-2029)
10.2.1 United States Orthopedic Regenerative Medicine Market Forecast
10.2.2 Canada Orthopedic Regenerative Medicine Market Forecast
10.2.3 Mexico Orthopedic Regenerative Medicine Market Forecast
10.2.4 Brazil Orthopedic Regenerative Medicine Market Forecast
10.3 APAC Orthopedic Regenerative Medicine Forecast by Region (2024-2029)
10.3.1 China Orthopedic Regenerative Medicine Market Forecast
10.3.2 Japan Orthopedic Regenerative Medicine Market Forecast
10.3.3 Korea Orthopedic Regenerative Medicine Market Forecast
10.3.4 Southeast Asia Orthopedic Regenerative Medicine Market Forecast
10.3.5 India Orthopedic Regenerative Medicine Market Forecast
10.3.6 Australia Orthopedic Regenerative Medicine Market Forecast
10.4 Europe Orthopedic Regenerative Medicine Forecast by Country (2024-2029)
10.4.1 Germany Orthopedic Regenerative Medicine Market Forecast
10.4.2 France Orthopedic Regenerative Medicine Market Forecast
10.4.3 UK Orthopedic Regenerative Medicine Market Forecast
10.4.4 Italy Orthopedic Regenerative Medicine Market Forecast
10.4.5 Russia Orthopedic Regenerative Medicine Market Forecast
10.5 Middle East & Africa Orthopedic Regenerative Medicine Forecast by Region (2024-2029)
10.5.1 Egypt Orthopedic Regenerative Medicine Market Forecast
10.5.2 South Africa Orthopedic Regenerative Medicine Market Forecast
10.5.3 Israel Orthopedic Regenerative Medicine Market Forecast
10.5.4 Turkey Orthopedic Regenerative Medicine Market Forecast
10.5.5 GCC Countries Orthopedic Regenerative Medicine Market Forecast
10.6 Global Orthopedic Regenerative Medicine Forecast by Type (2024-2029)
10.7 Global Orthopedic Regenerative Medicine Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Ortho Regenerative Technologies Inc
11.1.1 Ortho Regenerative Technologies Inc Company Information
11.1.2 Ortho Regenerative Technologies Inc Orthopedic Regenerative Medicine Product Offered
11.1.3 Ortho Regenerative Technologies Inc Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Ortho Regenerative Technologies Inc Main Business Overview
11.1.5 Ortho Regenerative Technologies Inc Latest Developments
11.2 Personalized stem cells Inc.
11.2.1 Personalized stem cells Inc. Company Information
11.2.2 Personalized stem cells Inc. Orthopedic Regenerative Medicine Product Offered
11.2.3 Personalized stem cells Inc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Personalized stem cells Inc. Main Business Overview
11.2.5 Personalized stem cells Inc. Latest Developments
11.3 Anika Therapeutics Inc.
11.3.1 Anika Therapeutics Inc. Company Information
11.3.2 Anika Therapeutics Inc. Orthopedic Regenerative Medicine Product Offered
11.3.3 Anika Therapeutics Inc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Anika Therapeutics Inc. Main Business Overview
11.3.5 Anika Therapeutics Inc. Latest Developments
11.4 Arthrex Inc.
11.4.1 Arthrex Inc. Company Information
11.4.2 Arthrex Inc. Orthopedic Regenerative Medicine Product Offered
11.4.3 Arthrex Inc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Arthrex Inc. Main Business Overview
11.4.5 Arthrex Inc. Latest Developments
11.5 Baxter International Inc.
11.5.1 Baxter International Inc. Company Information
11.5.2 Baxter International Inc. Orthopedic Regenerative Medicine Product Offered
11.5.3 Baxter International Inc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Baxter International Inc. Main Business Overview
11.5.5 Baxter International Inc. Latest Developments
11.6 Conmed Corporation
11.6.1 Conmed Corporation Company Information
11.6.2 Conmed Corporation Orthopedic Regenerative Medicine Product Offered
11.6.3 Conmed Corporation Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Conmed Corporation Main Business Overview
11.6.5 Conmed Corporation Latest Developments
11.7 Aziyo Biologics
11.7.1 Aziyo Biologics Company Information
11.7.2 Aziyo Biologics Orthopedic Regenerative Medicine Product Offered
11.7.3 Aziyo Biologics Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Aziyo Biologics Main Business Overview
11.7.5 Aziyo Biologics Latest Developments
11.8 Curasan Inc.
11.8.1 Curasan Inc. Company Information
11.8.2 Curasan Inc. Orthopedic Regenerative Medicine Product Offered
11.8.3 Curasan Inc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Curasan Inc. Main Business Overview
11.8.5 Curasan Inc. Latest Developments
11.9 Swiss biomed Orthopedics AG
11.9.1 Swiss biomed Orthopedics AG Company Information
11.9.2 Swiss biomed Orthopedics AG Orthopedic Regenerative Medicine Product Offered
11.9.3 Swiss biomed Orthopedics AG Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Swiss biomed Orthopedics AG Main Business Overview
11.9.5 Swiss biomed Orthopedics AG Latest Developments
11.10 Octane Medical Inc.
11.10.1 Octane Medical Inc. Company Information
11.10.2 Octane Medical Inc. Orthopedic Regenerative Medicine Product Offered
11.10.3 Octane Medical Inc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Octane Medical Inc. Main Business Overview
11.10.5 Octane Medical Inc. Latest Developments
11.11 Stryker Corporation
11.11.1 Stryker Corporation Company Information
11.11.2 Stryker Corporation Orthopedic Regenerative Medicine Product Offered
11.11.3 Stryker Corporation Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Stryker Corporation Main Business Overview
11.11.5 Stryker Corporation Latest Developments
11.12 Carmell Therapeutics Corporation
11.12.1 Carmell Therapeutics Corporation Company Information
11.12.2 Carmell Therapeutics Corporation Orthopedic Regenerative Medicine Product Offered
11.12.3 Carmell Therapeutics Corporation Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Carmell Therapeutics Corporation Main Business Overview
11.12.5 Carmell Therapeutics Corporation Latest Developments
11.13 Zimmer Holdings
11.13.1 Zimmer Holdings Company Information
11.13.2 Zimmer Holdings Orthopedic Regenerative Medicine Product Offered
11.13.3 Zimmer Holdings Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Zimmer Holdings Main Business Overview
11.13.5 Zimmer Holdings Latest Developments
11.14 Smith & Nephew plc.
11.14.1 Smith & Nephew plc. Company Information
11.14.2 Smith & Nephew plc. Orthopedic Regenerative Medicine Product Offered
11.14.3 Smith & Nephew plc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Smith & Nephew plc. Main Business Overview
11.14.5 Smith & Nephew plc. Latest Developments
11.15 NuVasive Inc.
11.15.1 NuVasive Inc. Company Information
11.15.2 NuVasive Inc. Orthopedic Regenerative Medicine Product Offered
11.15.3 NuVasive Inc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 NuVasive Inc. Main Business Overview
11.15.5 NuVasive Inc. Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Orthopedic Regenerative Medicine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Stem Cell Therapy (Allogeneic Bones, Autogeneic Bones, and Bone Grafting) Table 3. Major Players of Plasma Based Therapy Table 4. Major Players of Tissue Engineering (Allograft) Table 5. Orthopedic Regenerative Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 6. Global Orthopedic Regenerative Medicine Market Size by Type (2018-2023) & ($ Millions) Table 7. Global Orthopedic Regenerative Medicine Market Size Market Share by Type (2018-2023) Table 8. Orthopedic Regenerative Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 9. Global Orthopedic Regenerative Medicine Market Size by Application (2018-2023) & ($ Millions) Table 10. Global Orthopedic Regenerative Medicine Market Size Market Share by Application (2018-2023) Table 11. Global Orthopedic Regenerative Medicine Revenue by Players (2018-2023) & ($ Millions) Table 12. Global Orthopedic Regenerative Medicine Revenue Market Share by Player (2018-2023) Table 13. Orthopedic Regenerative Medicine Key Players Head office and Products Offered Table 14. Orthopedic Regenerative Medicine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global Orthopedic Regenerative Medicine Market Size by Regions 2018-2023 & ($ Millions) Table 18. Global Orthopedic Regenerative Medicine Market Size Market Share by Regions (2018-2023) Table 19. Global Orthopedic Regenerative Medicine Revenue by Country/Region (2018-2023) & ($ millions) Table 20. Global Orthopedic Regenerative Medicine Revenue Market Share by Country/Region (2018-2023) Table 21. Americas Orthopedic Regenerative Medicine Market Size by Country (2018-2023) & ($ Millions) Table 22. Americas Orthopedic Regenerative Medicine Market Size Market Share by Country (2018-2023) Table 23. Americas Orthopedic Regenerative Medicine Market Size by Type (2018-2023) & ($ Millions) Table 24. Americas Orthopedic Regenerative Medicine Market Size Market Share by Type (2018-2023) Table 25. Americas Orthopedic Regenerative Medicine Market Size by Application (2018-2023) & ($ Millions) Table 26. Americas Orthopedic Regenerative Medicine Market Size Market Share by Application (2018-2023) Table 27. APAC Orthopedic Regenerative Medicine Market Size by Region (2018-2023) & ($ Millions) Table 28. APAC Orthopedic Regenerative Medicine Market Size Market Share by Region (2018-2023) Table 29. APAC Orthopedic Regenerative Medicine Market Size by Type (2018-2023) & ($ Millions) Table 30. APAC Orthopedic Regenerative Medicine Market Size Market Share by Type (2018-2023) Table 31. APAC Orthopedic Regenerative Medicine Market Size by Application (2018-2023) & ($ Millions) Table 32. APAC Orthopedic Regenerative Medicine Market Size Market Share by Application (2018-2023) Table 33. Europe Orthopedic Regenerative Medicine Market Size by Country (2018-2023) & ($ Millions) Table 34. Europe Orthopedic Regenerative Medicine Market Size Market Share by Country (2018-2023) Table 35. Europe Orthopedic Regenerative Medicine Market Size by Type (2018-2023) & ($ Millions) Table 36. Europe Orthopedic Regenerative Medicine Market Size Market Share by Type (2018-2023) Table 37. Europe Orthopedic Regenerative Medicine Market Size by Application (2018-2023) & ($ Millions) Table 38. Europe Orthopedic Regenerative Medicine Market Size Market Share by Application (2018-2023) Table 39. Middle East & Africa Orthopedic Regenerative Medicine Market Size by Region (2018-2023) & ($ Millions) Table 40. Middle East & Africa Orthopedic Regenerative Medicine Market Size Market Share by Region (2018-2023) Table 41. Middle East & Africa Orthopedic Regenerative Medicine Market Size by Type (2018-2023) & ($ Millions) Table 42. Middle East & Africa Orthopedic Regenerative Medicine Market Size Market Share by Type (2018-2023) Table 43. Middle East & Africa Orthopedic Regenerative Medicine Market Size by Application (2018-2023) & ($ Millions) Table 44. Middle East & Africa Orthopedic Regenerative Medicine Market Size Market Share by Application (2018-2023) Table 45. Key Market Drivers & Growth Opportunities of Orthopedic Regenerative Medicine Table 46. Key Market Challenges & Risks of Orthopedic Regenerative Medicine Table 47. Key Industry Trends of Orthopedic Regenerative Medicine Table 48. Global Orthopedic Regenerative Medicine Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 49. Global Orthopedic Regenerative Medicine Market Size Market Share Forecast by Regions (2024-2029) Table 50. Global Orthopedic Regenerative Medicine Market Size Forecast by Type (2024-2029) & ($ Millions) Table 51. Global Orthopedic Regenerative Medicine Market Size Forecast by Application (2024-2029) & ($ Millions) Table 52. Ortho Regenerative Technologies Inc Details, Company Type, Orthopedic Regenerative Medicine Area Served and Its Competitors Table 53. Ortho Regenerative Technologies Inc Orthopedic Regenerative Medicine Product Offered Table 54. Ortho Regenerative Technologies Inc Orthopedic Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 55. Ortho Regenerative Technologies Inc Main Business Table 56. Ortho Regenerative Technologies Inc Latest Developments Table 57. Personalized stem cells Inc. Details, Company Type, Orthopedic Regenerative Medicine Area Served and Its Competitors Table 58. Personalized stem cells Inc. Orthopedic Regenerative Medicine Product Offered Table 59. Personalized stem cells Inc. Main Business Table 60. Personalized stem cells Inc. Orthopedic Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 61. Personalized stem cells Inc. Latest Developments Table 62. Anika Therapeutics Inc. Details, Company Type, Orthopedic Regenerative Medicine Area Served and Its Competitors Table 63. Anika Therapeutics Inc. Orthopedic Regenerative Medicine Product Offered Table 64. Anika Therapeutics Inc. Main Business Table 65. Anika Therapeutics Inc. Orthopedic Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 66. Anika Therapeutics Inc. Latest Developments Table 67. Arthrex Inc. Details, Company Type, Orthopedic Regenerative Medicine Area Served and Its Competitors Table 68. Arthrex Inc. Orthopedic Regenerative Medicine Product Offered Table 69. Arthrex Inc. Main Business Table 70. Arthrex Inc. Orthopedic Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 71. Arthrex Inc. Latest Developments Table 72. Baxter International Inc. Details, Company Type, Orthopedic Regenerative Medicine Area Served and Its Competitors Table 73. Baxter International Inc. Orthopedic Regenerative Medicine Product Offered Table 74. Baxter International Inc. Main Business Table 75. Baxter International Inc. Orthopedic Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 76. Baxter International Inc. Latest Developments Table 77. Conmed Corporation Details, Company Type, Orthopedic Regenerative Medicine Area Served and Its Competitors Table 78. Conmed Corporation Orthopedic Regenerative Medicine Product Offered Table 79. Conmed Corporation Main Business Table 80. Conmed Corporation Orthopedic Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 81. Conmed Corporation Latest Developments Table 82. Aziyo Biologics Details, Company Type, Orthopedic Regenerative Medicine Area Served and Its Competitors Table 83. Aziyo Biologics Orthopedic Regenerative Medicine Product Offered Table 84. Aziyo Biologics Main Business Table 85. Aziyo Biologics Orthopedic Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 86. Aziyo Biologics Latest Developments Table 87. Curasan Inc. Details, Company Type, Orthopedic Regenerative Medicine Area Served and Its Competitors Table 88. Curasan Inc. Orthopedic Regenerative Medicine Product Offered Table 89. Curasan Inc. Main Business Table 90. Curasan Inc. Orthopedic Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 91. Curasan Inc. Latest Developments Table 92. Swiss biomed Orthopedics AG Details, Company Type, Orthopedic Regenerative Medicine Area Served and Its Competitors Table 93. Swiss biomed Orthopedics AG Orthopedic Regenerative Medicine Product Offered Table 94. Swiss biomed Orthopedics AG Main Business Table 95. Swiss biomed Orthopedics AG Orthopedic Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 96. Swiss biomed Orthopedics AG Latest Developments Table 97. Octane Medical Inc. Details, Company Type, Orthopedic Regenerative Medicine Area Served and Its Competitors Table 98. Octane Medical Inc. Orthopedic Regenerative Medicine Product Offered Table 99. Octane Medical Inc. Main Business Table 100. Octane Medical Inc. Orthopedic Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 101. Octane Medical Inc. Latest Developments Table 102. Stryker Corporation Details, Company Type, Orthopedic Regenerative Medicine Area Served and Its Competitors Table 103. Stryker Corporation Orthopedic Regenerative Medicine Product Offered Table 104. Stryker Corporation Orthopedic Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 105. Stryker Corporation Main Business Table 106. Stryker Corporation Latest Developments Table 107. Carmell Therapeutics Corporation Details, Company Type, Orthopedic Regenerative Medicine Area Served and Its Competitors Table 108. Carmell Therapeutics Corporation Orthopedic Regenerative Medicine Product Offered Table 109. Carmell Therapeutics Corporation Main Business Table 110. Carmell Therapeutics Corporation Orthopedic Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 111. Carmell Therapeutics Corporation Latest Developments Table 112. Zimmer Holdings Details, Company Type, Orthopedic Regenerative Medicine Area Served and Its Competitors Table 113. Zimmer Holdings Orthopedic Regenerative Medicine Product Offered Table 114. Zimmer Holdings Main Business Table 115. Zimmer Holdings Orthopedic Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 116. Zimmer Holdings Latest Developments Table 117. Smith & Nephew plc. Details, Company Type, Orthopedic Regenerative Medicine Area Served and Its Competitors Table 118. Smith & Nephew plc. Orthopedic Regenerative Medicine Product Offered Table 119. Smith & Nephew plc. Main Business Table 120. Smith & Nephew plc. Orthopedic Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 121. Smith & Nephew plc. Latest Developments Table 122. NuVasive Inc. Details, Company Type, Orthopedic Regenerative Medicine Area Served and Its Competitors Table 123. NuVasive Inc. Orthopedic Regenerative Medicine Product Offered Table 124. NuVasive Inc. Main Business Table 125. NuVasive Inc. Orthopedic Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 126. NuVasive Inc. Latest Developments List of Figures Figure 1. Orthopedic Regenerative Medicine Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Orthopedic Regenerative Medicine Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. Orthopedic Regenerative Medicine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. Orthopedic Regenerative Medicine Sales Market Share by Country/Region (2022) Figure 8. Orthopedic Regenerative Medicine Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global Orthopedic Regenerative Medicine Market Size Market Share by Type in 2022 Figure 10. Orthopedic Regenerative Medicine in Osteoarticular Diseases Figure 11. Global Orthopedic Regenerative Medicine Market: Osteoarticular Diseases (2018-2023) & ($ Millions) Figure 12. Orthopedic Regenerative Medicine in Rheumatoid Arthritis Figure 13. Global Orthopedic Regenerative Medicine Market: Rheumatoid Arthritis (2018-2023) & ($ Millions) Figure 14. Orthopedic Regenerative Medicine in Ligament Injuries Figure 15. Global Orthopedic Regenerative Medicine Market: Ligament Injuries (2018-2023) & ($ Millions) Figure 16. Orthopedic Regenerative Medicine in Bursitis Figure 17. Global Orthopedic Regenerative Medicine Market: Bursitis (2018-2023) & ($ Millions) Figure 18. Orthopedic Regenerative Medicine in Osteoporosis Figure 19. Global Orthopedic Regenerative Medicine Market: Osteoporosis (2018-2023) & ($ Millions) Figure 20. Global Orthopedic Regenerative Medicine Market Size Market Share by Application in 2022 Figure 21. Global Orthopedic Regenerative Medicine Revenue Market Share by Player in 2022 Figure 22. Global Orthopedic Regenerative Medicine Market Size Market Share by Regions (2018-2023) Figure 23. Americas Orthopedic Regenerative Medicine Market Size 2018-2023 ($ Millions) Figure 24. APAC Orthopedic Regenerative Medicine Market Size 2018-2023 ($ Millions) Figure 25. Europe Orthopedic Regenerative Medicine Market Size 2018-2023 ($ Millions) Figure 26. Middle East & Africa Orthopedic Regenerative Medicine Market Size 2018-2023 ($ Millions) Figure 27. Americas Orthopedic Regenerative Medicine Value Market Share by Country in 2022 Figure 28. United States Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 29. Canada Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 30. Mexico Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 31. Brazil Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 32. APAC Orthopedic Regenerative Medicine Market Size Market Share by Region in 2022 Figure 33. APAC Orthopedic Regenerative Medicine Market Size Market Share by Type in 2022 Figure 34. APAC Orthopedic Regenerative Medicine Market Size Market Share by Application in 2022 Figure 35. China Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 36. Japan Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 37. Korea Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 38. Southeast Asia Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 39. India Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 40. Australia Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 41. Europe Orthopedic Regenerative Medicine Market Size Market Share by Country in 2022 Figure 42. Europe Orthopedic Regenerative Medicine Market Size Market Share by Type (2018-2023) Figure 43. Europe Orthopedic Regenerative Medicine Market Size Market Share by Application (2018-2023) Figure 44. Germany Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 45. France Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 46. UK Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 47. Italy Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 48. Russia Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 49. Middle East & Africa Orthopedic Regenerative Medicine Market Size Market Share by Region (2018-2023) Figure 50. Middle East & Africa Orthopedic Regenerative Medicine Market Size Market Share by Type (2018-2023) Figure 51. Middle East & Africa Orthopedic Regenerative Medicine Market Size Market Share by Application (2018-2023) Figure 52. Egypt Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 53. South Africa Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 54. Israel Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 55. Turkey Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 56. GCC Country Orthopedic Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 57. Americas Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 58. APAC Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 59. Europe Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 60. Middle East & Africa Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 61. United States Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 62. Canada Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 63. Mexico Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 64. Brazil Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 65. China Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 66. Japan Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 67. Korea Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 68. Southeast Asia Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 69. India Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 70. Australia Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 71. Germany Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 72. France Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 73. UK Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 74. Italy Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 75. Russia Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 76. Spain Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 77. Egypt Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 78. South Africa Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 79. Israel Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 80. Turkey Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 81. GCC Countries Orthopedic Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 82. Global Orthopedic Regenerative Medicine Market Size Market Share Forecast by Type (2024-2029) Figure 83. Global Orthopedic Regenerative Medicine Market Size Market Share Forecast by Application (2024-2029)
